Eyetech deal gives quick access to new research

New York-Eyetech Pharmaceuticals and Archemix Corp. will collaborate on the research and development of aptamers for use in the treatment of ophthalmic diseases.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.